| |
| |
|
| Insider
Information: |
White Christopher G |
| Relationship: |
Chief Business Officer |
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
152,089 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$390,500 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
152,089 |
|
|
| Total
Value |
$390,500 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
AMAG Pharmaceuticals Inc |
AMAG |
Chief Business Officer |
2014-02-27 |
28,400 |
2012-01-09 |
0 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
Chief Business Officer |
2024-02-05 |
123,689 |
2022-02-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCUL |
Ocular Therapeutix, Inc |
Chief Business Officer |
• – – |
2024-02-05 |
4 |
S |
$4.86 |
$28,723 |
D/D |
(5,910) |
123,689 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Business Officer |
• – – |
2024-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
39,980 |
129,599 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Business Officer |
• – – |
2024-01-31 |
4 |
S |
$4.95 |
$25,478 |
D/D |
(5,147) |
89,619 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Business Officer |
• – – |
2023-02-06 |
4 |
AS |
$4.24 |
$24,715 |
D/D |
(5,829) |
94,766 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Business Officer |
• – – |
2023-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
44,444 |
100,595 |
0 |
- |
|
| OCUL |
Ocular Therapeutix, Inc |
Chief Business Officer |
• – – |
2022-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
52,127 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,400 |
28,400 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2014-02-26 |
4 |
AS |
$21.58 |
$8,632 |
D/D |
(400) |
24,000 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2014-02-25 |
4 |
AS |
$21.71 |
$9,422 |
D/D |
(434) |
24,400 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2014-01-09 |
4 |
AS |
$20.61 |
$41,659 |
D/D |
(2,000) |
24,834 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2014-01-08 |
4 |
AS |
$23.91 |
$47,820 |
D/D |
(2,000) |
26,834 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2014-01-07 |
4 |
AS |
$24.10 |
$60,250 |
D/D |
(2,500) |
28,834 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2014-01-06 |
4 |
AS |
$23.69 |
$59,225 |
D/D |
(2,500) |
31,334 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2013-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2013-02-26 |
4 |
AS |
$16.37 |
$6,548 |
D/D |
(400) |
0 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2013-02-25 |
4 |
AS |
$16.39 |
$7,097 |
D/D |
(433) |
400 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2013-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
833 |
833 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2013-01-09 |
4 |
AS |
$15.80 |
$47,407 |
D/D |
(3,000) |
0 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2013-01-08 |
4 |
AS |
$15.87 |
$47,600 |
D/D |
(3,000) |
3,000 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2013-01-07 |
4 |
AS |
$16.07 |
$64,285 |
D/D |
(4,000) |
2,000 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2013-01-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,000 |
6,000 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2013-01-04 |
4 |
AS |
$16.03 |
$64,102 |
D/D |
(4,000) |
6,000 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer |
• – – |
2013-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer, SVP |
• – – |
2012-08-06 |
4 |
AS |
$14.29 |
$53,588 |
D/D |
(3,750) |
0 |
0 |
- |
|
| AMAG |
AMAG Pharmaceuticals Inc |
Chief Business Officer, SVP |
• – – |
2012-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,750 |
3,750 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
